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Abstract                                                                               
Completely 538 clinical specimens of blood, wounds, burns, sputum and urine were included in this study 
which was carried out in 4 hospitals. The isolation and diagnosis of fifty-two Acinetobacter baumannii isolate 
36.54% from blood specimens, whereas wounds specimens constituted 23.08%, burns specimens achieved 
17.31%, sputum specimens formed 13.46% and a low percentage was in urine specimens which accomplished 9.62 
%. Totally isolates of bacteria were identified via the biochemical, cultural and microbial characteristics and 
confirmed via VITEK 2 Compact system. It was found that all (100%) of bacteria isolates were resistant to 
amoxicillin-clavulanic acid and Cefepime, while Imipenem and Meropenem were the most effective antibiotics. 
The isolates showed the ability of biofilm production by Microtitration plates method (M.T.P), from the total 
number (52) isolate tested for biofilm formation,(33) were producers,  as strong biofilm producers were (15) 45.46 
% and (18)54.54% moderate while (19) 36.53% isolates were measured as none or weak producers of biofilm. 
MIC for new hydantoin derivative (C11H11N3O2S) was determined against fifteen isolates were active in MIC 
values equal to 250g/ml gave (9) A. baumannii isolates, while in MIC, values equal to 125g/ml gave (6) 
isolates. 
 
The results showed the inhibitory effect of the hydantoin compound on biofilm formation for 15 bacterial 
isolates used in this study with variable inhibitory effect on bacterial isolates ranged from 79.72% to 98.85%. The 
highest inhibitory effect percentage is (98.85%). 
 
1-Introduction  
         Infectious diseases are stay a chief deaths cause especially in rising countries, for instance new infectious 
diseases ascend and a developing number of multi-drug resistant strains of microbial pathogens occur [1]. The 
latter hassle applies specifically to Gram-negative bacteria, such as A. baumannii. Multidrug resistance indicates a 
critical function in the letdown of remedy of cancer and infectious illnesses [2]. Microorganisms have developed 
various approaches to face up to the antibiotics poisonous effects and different capsules [3],[4].Discovery of 
chemotherapeutic marketers played a very necessary position in controlling and preventing such diseases. 
Chemotherapeutic dealers are remoted both from dwelling organisms recognized as antibiotics, or they are 
chemical compounds organized through chemist [5],[6]. Hydantoin derivatives have a diversity of biochemical and 
pharmacological traits and are used to deal with quite a few human ailments and extensive vary of other 
pharmacological characteristics, counting herbicidal, antitumor, anti-inflammatory, fungicidal, hypolipidemic, 
anti-HIV, antihypertensive and antiarrhythmic activities [7],[8]. A cinetobacter baumannii is a public causative 
agent of nosocomial infections and it has come to be a pathogen of enlarged clinical importance because of its 
first-rate functionality to reason outbreaks of infections and to obtain resistance to nearly definitely nowadays used 
antibiotics, involving the carbapenems [9],[10]. A. baumannii is characterised via its capability to spread, its 
capacity to continue to exist on an environmental surface [11]. And its tremendous easiness with which it obtains 
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antimicrobial multiple resistance. The past 15 years, many A. baumannii nosocomial traces isolated worldwide are 
particularly resistant to nearly all available families of cutting-edge antibiotics [12],[13]. Biofilm-forming 
capability and antibiotic resistance are measured to be two serious elements for the accomplishment of A. 
baumannii as an ordinary nosocomial pathogen [14]. While, the formation of biofilm capability in spite of its vital 
function in the enchancment of resistance of antibiotic and pathogenesis of A. baumannii has been poorly 
examined [15],[16].   
                                                                                                                         
2-Aim of the Study 
      Synthesis and analyzing for new hydantoin derivative (compound) as a precise antimicrobial action which may 
be suitable to be used as chemotherapeutic means.                                                                        
 
3- Materials and Methods 
3.1Samples collection  
    A whole of 538 clinical samples of blood, wounds, burns, sputum and urine were included in present study 
which was carried out in 4 hospitals. Through  the period ranging from 1 February 2017 until June 2017.  Bacterial 
diagnosis initially diagnostic depending on Gram reaction and morphological characteristics of the colonies based 
on bacterial growth on MacConkey agar and Blood agar, as well as the number of biochemical test and  Api 20 E 
strip reading . The second  technique VITEK 2 compact system. A. baumannii was distinguished by the following   
 methods; heamolysin test and IMVC test [17]. 
                                                                                                                                                                 
3.2 Susceptibility of Antibiotic  
      Experiment disk agar dissemination according to Kirby Baur standardized susceptibility of antimicrobial, 
single disk way was carried out toward twelve antibiotics.The antibiotic discs were as follows:, Ciprofloxacin 
(CIP, 5µg/disc) , Piperacillin (PIP, 100µg/disc) Tobramycin (TB, 10µg/disc), ceftriaxone(CTR, 30µg/disc ) , 
Ceftazidime(CAZ, 30µg/disc), Cefepime (CFP ,30µg/disc), Aztreonam(ATM, 30µg/disc), Amoxicillin-
Clavulanicacid (AUC, 20/10µg/disc ), Amikacin (AK,30µg/disc) , Gentamicin(CN, 10µg/disc), Meropenem 
(MEM,10µg/disc ) and Imipenem (IMP, 10µg/disc), Bioanalyse  (Turkey)  [18].                         
                                              
3.3Biofilm Formation                                                                                       
The bacterial activity for biofilm formation was measured by quantitation of biofilm by microtiter plate 
(M.T.P): The current study screened the all medical isolates of A. baumannii for their capability to biofilm 
formation via microtitration plates approach as stated by way of [19]. With some modification, A. baumannii were 
inoculated in three ml of brain heart infusion (BHI) with 1% glucose [20]. The broth was incubated for 24 h at 
37ºC. 200 µL aliquots of only BHI + 1% glucose previously prepared were distributed into 3 wells of the column 
one of microtitration plate to function as a control and 200 µL of the diluted cultures were added to the wells of the 
microtitration plate and incubation for 24 h at 37°C.Adherent micro-organisms forming biofilms were static with 
sodium acetate (2%) and marked with crystal violet (0.1% w/v), and permitted to incubate for 15 min at room 
temperature. After eliminating the crystal violet solution, wells were washed 3 times with distilled water to 
eliminate boundless dye. Lastly, totally wells were filled via 200 µL ethanol (95%) to discharge the dye from the 
cells and Optical density (OD) of biofilm was obtained by using ELISA reader at wavelength 550 nm. 
 
 The ability of biofilm formation=O.D of test sample - O.D of quality control. 
Experimental reparation of 3- ((1-(4-hydroxyphenyl) ethylidene) amino) -2-thioxoimidazolidin - 4- one   
    New hydantion derivatives were prepared according to the literature procedure [21, 22]. In this study, new 
hydantion derivative was used compound 3-((1-(4-hydroxyphenyl) ethylidene) amino)-2-thioxoimidazolidin-4-one 
(C11H11N3O2S), and it melting point was detected (205-210˚C) and prepared as follow: carbonyl compounds 
(0.01mole) was dissolved in ethanol (30 ml) and (0.01mole) of thiosemicarbazide was added and then refluxed for 
three hrs. The resultant mixture was transferred into crushed ice and stirred for 15 min. Then the precipitated 
crystalline solids were filtered, laundered with water and were recrystallized from ethanol.Moreover, (0.01mole) of 
compounds2-(1-(4-hydroxyphenyl) ethylidene) hydrazine-1-carbothioamide were dissolved and their melting point 
were detected (185-1880˚C) C9H11N3OS and (0.01 mole) of chloroethylacetate in 30 ml ethanol to obtain a 
mixture. The mixtures were stirred for a few minutes, and then sodium acetate (0.02mole) was additional to the 
mixture. The mixture was refluxed for 6hrs. After cooling, the precipitate found which is filtered off and 
recrystallization from dioxane. 
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3.4 Determination of minimum inhibitory concentrations (MICs) of new hydantoin compounds for A. 
baumannii isolates  
The antimicrobial efficiency of new hydantoin derivative (4-hydroxyphenyl) ethylidene) amino)-2-
thioxoimidazolidin-4-one) against A. baumannii was tested by the standard broth dilution approach. By using serial 
two-fold dilutions of new hydantoin derivative in concentrations extending from (15.62 mg/ml to 500 mg/ml) the 
MIC was determined in BHI broth. In present study, wield the positive control contained BHI broth medium with 
experienced bacterial concentrations and negative control contained only BHI broth and incubated at 370C for 
24hr. The (MIC) of the new hydantoin derivative for A. baumannii was measured at the lowest concentration of the 
new hydantoin compound required to inhibit the A. baumannii growth. 
3.5The antimicrobial activity of the new hydantoin compounds for biofilm formation on A. baumannii 
isolates 
The antimicrobial activity of the new hydantoin derivative against A. baumannii isolates used to be 
quantified according to the process described via [23], [24].  
Briefly, wells of sterile ninety six well-flat bottom polystyrene tissue tradition dealt with plates had been 
stuffed with 200µL of the diluted cultures (180 µL BHI+ 1% glucose and20 µL bacterial culture) serve as a control 
.While the second well was filled with100 µl of the hydantoin compound in concentration of Sub MICs with 100 
µl BHI containing bacterial culture and covering with parafilm. The plate was once incubated at 37°C for 24 h and 
later washed twice with distilled water and left to dry at room temperature for 15 min. Then we added 200µL of 
the crystal violet to all wells and left for twenty min. Later wells washed by sterile water and left to dry at room 
temperature for fifteen min. Subsequently for removing the crystal violet, wells were washed 3 times with D.W to 
eliminate boundless dye. 
 Lastly, totally wells were filled via 200 µL ethanol (95%)  to discharge the dye from the cells and optical 
density of stained biofilm was gained through using micro ELISA auto reader at wavelength 595 nm. 
% of inhibition of biofilm formation = 1- (Sample optical density /control optical density) ×100 
 
4- Results and Discussion 
4.1 Isolation and Identification of Bacterial Isolates  
A total of 538 clinical specimens of blood, wounds, burns, sputum and urine were included in this study, 
52 were positive to A. baumannii which was isolated in high percentage; 36.54% (n=19) from blood specimens; 
whereas, wounds specimens constituted 23.08% (n= 12), burns specimens achieved 17.31% (n= 9), sputum 
specimens formed 13.46% (n= 7) and low percentage was in urine specimens which accomplished 9.62 % (n= 5). 
All bacterial samples expected to be an A. baumannii grown on MacConkey agar and Blood agar as 
enrichment media, then it occurs as Gram-negative coccobacilli and occasionally arranged in diplococcic under the 
microscope .Then, anumber of biochemical test were carried out and the results showed in table (1). 
 
Table 1: Biochemical test consequences for Acinetobacter baumannii 
RESULT TEST ID 
+ Catalase production 1 
+ Citrate utilization 2 
+ Growth at 44ºC 3 
_ (γ hemolysis) Hemolysin production 4 
_ Motility  5 
_ Urease production 6 
_ Indole production 7 
_ Oxidase production 8 
Alkaline slant / No change bottom, No gas , 
No H2S 
Kliglar iron agar (KIA) 9 
- Lactose fermentation  10 
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All the above results were identification by Api 20 E strip reading and Vitek 2 compact system (17). 
 
 
Figure 1: Results for   A. baumannii  by API 20 E system. 
 
4.2 Antibiotics Susceptibility 
 The susceptibility tests toward (12) antibiotics were carried out and results are illustrated in Figure (2) 
which showed that A. baumannii clinical isolates had 100% resistance to Amoxicillin-clavulanic acid and 
Cefepime. Also this study showed the highest resistance to Ceftriaxone (94.23%), Piperacillin (94.23%), 
Ceftazidime (90.38%), Aztreonam (88.46%), Gentamicin (86.53%), Ciprofloxacin (82.69%) and Amikacin 
(73.07%). Imipenem and Meropenem recorded moderate resistance; (55.76%) both them.It is worthy to remark 
that from 52 clinical isolates of A. baumannii, 21 isolates (40.38%) were resistant to Tobramycin. 
 
 
Figure 2: Antibiotic resistance of Acinetobacter baumannii isolates. 
 
In a local study done via [25], reported that A. baumannii clinical isolates showed 100% resistance to 
Cefotaxime, Ceftazidime, Ceftriaxone, 95.45 % to Cefepime, Chloramphenicol, Aztronam and 40.90% to 
Imipenem.  According to these local studies, can remark interestingly the increasing of resistance to Imipenem 
antibiotic in our hospitals. 
[26] reported that >75% of their isolates were resistant to Imipenem, Meropenem and other antibiotics usually used 
for the handling of A. baumannii. Another study conducted by [27] reported a high level of resistance to Imipenem 
and Meropenem (55.6%) as well. [28] reported that the resistance percentage of Imipenem was (43.59%) for A. 
baumannii isolates. 
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4.3 Biofilm Formation by A. baumannii 
The capacity of A .baumannii to the production of biofilm by all isolates from (blood, wound, burns swab 
and sputum as well as urine).   MTP technique, from the whole number of (52) isolates verified for biofilm 
formation,(33) were producers,  as strong biofilm producers were (15) 45.46 % and (18) 54.54% moderate while 
(19) 36.53% isolates were considered as none or weak biofilm producers figure 3.  
 
 
Figure 3: Biofilm producer MTP method by A .baumannii isolate 
 
Many bacterial pathogens, which include A. baumannii, can develop either as dispersed (planktonic) cells or 
as matrix-enclosed communities referred to as biofilms. The potential to form biofilm is shared amongst scientific 
A. baumannii isolates, possibly because the biofilm mode of increase contributes to the ecological success of this 
pathogen in the hospital [29].  
These consequences are disagreement with a study [29, 30] located that all A. baumannii isolates showed the 
ability to structure biofilms in MH broth. 
Another study additionally in total, 249 (91%) isolate had been fine for biofilm formation, and 63 (23%) 
isolates exhibited extra strong biofilm formation [31]. The results of [32] are establish that most of the A. 
baumannii isolates from both blood and sputum were capable to form variable degrees of biofilm on polystyrene. 
In study of [33] exhibited of the ninety-two isolates studied, 56 (63%) made biofilm in vitro, 33 (36%) did not 
form biofilm. Consequently [34] are revealed strongly positive via microtitre plate assay in (n=32) A. baumannii, 
while the residual isolates were either one moderate adherent (n=18) A. baumannii or feeble producers (n=13) A. 
baumannii and non-biofilm producers (n=11). 
 
4.4 Determination of Minimum Inhibitory Concentrations (MICs) of new hydantoin derivatives on 
A.baumannii 
MIC for new hydantoin derivative (C11H11N3O2S) was determined against fifteen isolates of A .baumannii 
were multi-drug resistance and biofilm formation with the method (MTP) was the best and the consequences were 
interpreted after 16-18 hrs.of incubation at 37oC according to the [35]. The (MIC) of the new compound for A 
.baumannii was measured at the lowermost concentration of the compound required to inhibit the growth of these 
micro-organisms, this plate containing different concentrations of the new hydantoin compound was incubated at 
370C for 16-18hr.The compound (C11H11N3O2S) was screened in vitro for its ability to inhibit the progression of A 
.baumannii.  The compound was active in MIC values equal to 250g/ml gave (9) A. baumannii isolates; while in 
MIC values equal to 125g/ml gave (6) isolates table 2.     
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4.5 The inhibition effect of new hydantoin derivative in Sub MICs concentration on Acinetobacter 
baumannii biofilm formation   
 
The inhibition effect of the new hydantion derivative was studied in Sub MICs concentration on A. 
baumannii biofilm formation by using microtiter plate method (MTP) which considered more sensitive and the 
best method in detection of bacterial adherent and biofilm formation [20].  
In Table (2) the results showed the inhibitory effect of the hydantoin compound on biofilm formation for 15 
bacterial isolates used in this study with variable inhibitory effect on bacterial isolates ranged from 79.72% to 
98.85%. The highest inhibitory effect percentage (98.85%) has appeared on the A. baumannii isolate number (14) 
was isolated from blood followed by 97.30%, 97.01%, 96.08% from Sputum, Wounds, Burns, respectively. While, 
the lowest inhibitory effect (79.72%) has appeared on the isolate number (36) was isolated from blood. Whereas, 
results showed that there were some differences in the values of the MICs of compound (1-1) in resistant of A. 
baumannii isolates ranged from 125µg/ml to 250µg/ml. Moreover, the results showed a significant difference 
(P<0.05) between the inhibition of biofilm rate and control. 
 
Table 2: Biofilm formation and percentage of inhibition of the hydantoin compound on A. baumannii 
isolates according to source 
 
No. of 
Isolates 
Sources MIC 
Biofilm              
formation 
Inhibition biofilm 
% of 
inhibition 
1 Blood 125 0.267 0.0186 93.03 
3 Wounds 250 0.268 0.008 97.01 
4 Burns 250 0.269 0.051 81.04 
6 Burns 250 0.230 0.009 96.08 
7 Wounds 250 0.192 0.006 96.87 
13 Sputum 125 0.200 0.004 98.00 
14 Blood 125 0.263 0.003 98.85 
17 Sputum 250 0.240 0.017 92.91 
28 Wounds 250 0.207 0.012 94.20 
31 Sputum 125 0.223 0.006 97.30 
32 Blood 250 0.222 0.045 79.72 
36 Burns 250 0.247 0.020 91.94 
39 Wounds 125 0.236 0.014 94.06 
42 Blood 125 0.203 0.023 88.66 
49 Wounds 250 0.284 0.016 94.36 
LSD value --- --- --- 0.0193 * --- 
* (P<0.05).  
 
Acinetobacter baumannii is a public causative agent of nosocomial infections and it has got a pathogen of 
augmented clinical importance because of its remarkable capability to cause outbreaks of infections and to gain 
resistance to nearly all presently used antibiotics [36].The results for the antimicrobial activity of hydantion 
derivatives are presented that it has potential as antimicrobial agent against bacteria[37]. 
5- Conclusions 
The results of all A. baumannii clinical isolates showed multidrug resistance but the resistance among Beta – 
lactam were more than among other antibiotics and the antimicrobial activity for new hydantoin derivatives 
showed great improvement of activity of these compounds against A. baumannii biofilm formation. 
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 Acinetobacter baumannii
amoxicillin-clavulanic acidCefepimeImipenem Meropenem
 Microtiter plate (M.T.P) 
MICMIC
 A. baumannii.250g/ml MIC125g/ml
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